Pirfenidone Inhibits Lung Allograft Fibrosis through L-Arginine–Arginase Pathway
Open Access
- 1 June 2005
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 5 (6) , 1256-1263
- https://doi.org/10.1111/j.1600-6143.2005.00876.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Gene Transfer of Inducible Nitric Oxide Synthase Complementary DNA Regresses the Fibrotic Plaque in an Animal Model of Peyronie’s Disease1Biology of Reproduction, 2004
- Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Heme-oxygenase-1 expression correlates with severity of acute cellular rejection in lung transplantationJournal of the American College of Surgeons, 2004
- Neuroprotective effects of spermine following hypoxia‐ischemia‐induced brain damage: A mechanistic studyThe FASEB Journal, 2004
- Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood VesselsCirculation, 2003
- REGULATION OFENZYMES OF THEUREACYCLE ANDARGININEMETABOLISMAnnual Review of Nutrition, 2002
- Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA‐salt hypertensive ratsBritish Journal of Pharmacology, 2002
- Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin‐diabetic ratsBritish Journal of Pharmacology, 2001
- Transforming growth factor beta (TGF-β) and obliterative bronchiolitis following pulmonary transplantationThe Journal of Heart and Lung Transplantation, 1999
- Transforming growth factor-β1 and lung allograft fibrosis1European Journal of Cardio-Thoracic Surgery, 1998